Delaware
|
0-22818
|
22-3240619
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
Exhibit
No.
|
Description
|
|
99.1
|
Press
Release dated August 26, 2008.
|
THE
HAIN CELESTIAL GROUP, INC.
|
||
(Registrant)
|
||
|
||
By:
|
/s/
Ira J. Lamel
|
|
Name:
|
Ira
J. Lamel
|
|
Title:
|
Executive
Vice President and
Chief
Financial Officer
|
Contact: | Ira Lamel/Mary Anthes | Jeremy Fielding/David Lilly |
The Hain Celestial Group, Inc. | Kekst and Company | |
631-730-2200 |
212-521-4800
|
· |
Delivered
solid sales and earnings growth despite a challenging economy and
commodity and other inflationary
pressures;
|
· |
Achieved
productivity gains resulting from a multi-year initiative, which,
combined
with price increases, mitigated escalating commodity
costs;
|
· |
Introduced
over 50 innovative new products in growth categories and subcategories,
exceeding the industry average for sales
contribution;
|
· |
Implemented
an SKU Rationalization in Personal Care, combining the operations
of
Avalon®, Alba®, JASON®, Zia® and Queen Helene®;
and
|
· |
Acquired
TenderCare®, MaraNatha®, SunSpire®, Daily Bread™ and Plainville Farms®
brands—brands with products in fast growing categories to complement
existing brands and product lines—and added production capacity for Hain
Pure Protein with acquired facilities in North Carolina and
Pennsylvania.
|
June
30,
|
June
30,
|
||||||
2008
|
2007
|
||||||
|
|||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
58,513
|
$
|
60,518
|
|||
Trade
receivables, net
|
118,867
|
95,405
|
|||||
Inventories
|
175,667
|
129,062
|
|||||
Deferred
income taxes
|
12,512
|
8,069
|
|||||
Other
current assets
|
27,482
|
22,950
|
|||||
Total
current assets
|
393,041
|
316,004
|
|||||
Property,
plant and equipment, net
|
159,089
|
114,901
|
|||||
Goodwill,
net
|
550,238
|
509,336
|
|||||
Trademarks
and other intangible assets, net
|
136,861
|
96,342
|
|||||
Other
assets
|
20,155
|
21,873
|
|||||
Total
assets
|
$
|
1,259,384
|
$
|
1,058,456
|
|||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable and accrued expenses
|
$
|
145,186
|
$
|
112,458
|
|||
Income
taxes payable
|
907
|
4,456
|
|||||
Current
portion of long-term debt
|
222
|
566
|
|||||
Total
current liabilities
|
146,315
|
117,480
|
|||||
Long-term
debt, less current portion
|
308,220
|
215,446
|
|||||
Deferred
income taxes
|
26,524
|
22,232
|
|||||
Other
noncurrent liabilities
|
5,012
|
664
|
|||||
Total
liabilities
|
486,071
|
355,822
|
|||||
Minority
Interest
|
30,502
|
5,678
|
|||||
Stockholders'
equity:
|
|||||||
Common
stock
|
411
|
409
|
|||||
Additional
paid-in capital
|
488,650
|
487,750
|
|||||
Retained
earnings
|
237,008
|
195,658
|
|||||
Foreign
currency translation adjustment
|
32,215
|
25,884
|
|||||
758,284
|
709,701
|
||||||
Less:
Treasury stock
|
(15,473
|
)
|
(12,745
|
)
|
|||
Total
stockholders' equity
|
742,811
|
696,956
|
|||||
Total
liabilities and stockholders' equity
|
$
|
1,259,384
|
$
|
1,058,456
|
Three Months Ended June 30,
|
Twelve Months Ended June 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
(Unaudited)
|
|||||||||||||
Net
sales
|
$
|
278,261
|
$
|
222,320
|
$
|
1,056,371
|
$
|
900,432
|
|||||
Cost
of sales
|
210,669
|
160,329
|
772,062
|
639,002
|
|||||||||
Gross
profit
|
67,592
|
61,991
|
284,309
|
261,430
|
|||||||||
SG&A
expenses
|
55,834
|
43,359
|
207,553
|
177,453
|
|||||||||
Operating
income
|
11,758
|
18,632
|
76,756
|
83,977
|
|||||||||
Interest
expense and other expenses
|
2,512
|
19
|
11,311
|
6,885
|
|||||||||
Income
before income taxes
|
9,246
|
18,613
|
65,445
|
77,092
|
|||||||||
Income
tax provision
|
2,742
|
6,473
|
24,224
|
29,610
|
|||||||||
Net
income
|
$
|
6,504
|
$
|
12,140
|
$
|
41,221
|
$
|
47,482
|
|||||
Basic
per share amounts
|
$
|
0.16
|
$
|
0.30
|
$
|
1.03
|
$
|
1.21
|
|||||
Diluted
per share amounts
|
$
|
0.16
|
$
|
0.29
|
$
|
0.99
|
$
|
1.16
|
|||||
Weighted
average common shares outstanding:
|
|||||||||||||
Basic
|
40,133
|
39,810
|
40,077
|
39,315
|
|||||||||
Diluted
|
41,550
|
41,706
|
41,765
|
41,108
|
Three
Months Ended June 30,
|
|||||||||||||
2008 GAAP
|
Adjustments
|
2008 Adjusted
|
2007 Adjusted
|
||||||||||
(Unaudited)
|
|||||||||||||
Net
sales
|
$
|
278,261
|
$
|
278,261
|
$
|
222,320
|
|||||||
Cost
of sales
|
210,669
|
$
|
(3,474
|
)
|
207,195
|
160,329
|
|||||||
Gross
profit
|
67,592
|
3,474
|
71,066
|
61,991
|
|||||||||
SG&A
expenses
|
55,834
|
(4,762
|
)
|
51,072
|
43,483
|
||||||||
|
|
|
|
||||||||||
Operating
income
|
11,758
|
8,236
|
19,994
|
18,508
|
|||||||||
Interest
and other expenses, net
|
2,512
|
2,512
|
3,136
|
||||||||||
Income
before income taxes
|
9,246
|
8,236
|
17,482
|
15,372
|
|||||||||
Income
tax provision
|
2,742
|
740
|
3,482
|
4,819
|
|||||||||
Net
income
|
$
|
6,504
|
$
|
7,496
|
$
|
14,000
|
$
|
10,553
|
|||||
Basic
per share amounts
|
$
|
0.16
|
$
|
0.35
|
$
|
0.27
|
|||||||
Diluted
per share amounts
|
$
|
0.16
|
$
|
0.34
|
$
|
0.25
|
|||||||
Weighted
average common shares outstanding:
|
|||||||||||||
Basic
|
40,133
|
40,133
|
39,810
|
||||||||||
Diluted
|
41,550
|
41,550
|
41,706
|
2008
|
2007
|
||||||||||||
Impact on Income
before income taxes
|
Impact on Income tax
provision
|
Impact on Income
before income taxes
|
Impact on Income tax
provision
|
||||||||||
(Unaudited)
|
|||||||||||||
Start-up
costs at the Fakenham manufacturing facility related to the integration
of
the Haldane Foods frozen meat-free operations
|
$
|
2,537
|
$
|
230
|
|||||||||
SKU
rationalization
|
937
|
285
|
|||||||||||
Cost
of sales
|
$
|
3,474
|
$
|
515
|
$
|
|
$
|
|
|||||
Professional
fees and other expenses incurred in connection with the review of
the
Company's stock option practices
|
$
|
1,079
|
$
|
462
|
$
|
281
|
$
|
105
|
|||||
Stock
compensation expense
|
2,273
|
(667
|
)
|
(405
|
)
|
(225
|
)
|
||||||
Severence
and other reorganization costs
|
1,410
|
430
|
|||||||||||
SG&A
expenses
|
$
|
4,762
|
$
|
225
|
$
|
(124
|
)
|
$
|
(120
|
)
|
|||
Gain
on the sale of Biomarché
|
$
|
|
$
|
|
$
|
(871
|
)
|
$
|
(677
|
)
|
|||
Reversal
of charge in connection with the decision by the German government
regarding application of VAT on non-dairy beverages
|
(2,246
|
)
|
(857
|
)
|
|||||||||
Interest
and other expenses, net
|
$
|
|
$
|
|
$
|
(3,117
|
)
|
$
|
(1,534
|
)
|
|||
Total
adjustments
|
$
|
8,236
|
$
|
740
|
$
|
(3,241
|
)
|
$
|
(1,654
|
)
|
Twelve
Months Ended June 30,
|
|||||||||||||
2008 GAAP
|
Adjustments
|
2008 Adjusted
|
2007 Adjusted
|
||||||||||
(Unaudited)
|
|||||||||||||
Net
sales
|
$
|
1,056,371
|
$
|
1,056,371
|
$
|
900,432
|
|||||||
Cost
of sales
|
772,062
|
$
|
(14,439
|
)
|
757,623
|
637,253
|
|||||||
Gross
profit
|
284,309
|
14,439
|
298,748
|
263,179
|
|||||||||
SG&A
expenses
|
207,553
|
(11,771
|
)
|
195,782
|
177,124
|
||||||||
|
|
|
|
||||||||||
Operating
income
|
76,756
|
26,210
|
102,966
|
86,055
|
|||||||||
Interest
and other expenses, net
|
11,311
|
2,002
|
13,313
|
10,286
|
|||||||||
Income
before income taxes
|
65,445
|
24,208
|
89,653
|
75,769
|
|||||||||
Income
tax provision
|
24,224
|
6,770
|
30,994
|
28,237
|
|||||||||
Net
income
|
$
|
41,221
|
$
|
17,438
|
$
|
58,659
|
$
|
47,532
|
|||||
Basic
per share amounts
|
$
|
1.03
|
|
$
|
1.46
|
$
|
1.21
|
||||||
Diluted
per share amounts
|
$
|
0.99
|
|
$
|
1.40
|
$
|
1.16
|
||||||
Weighted
average common shares outstanding:
|
|||||||||||||
Basic
|
40,077
|
|
40,077
|
39,315
|
|||||||||
Diluted
|
41,765
|
41,765
|
41,108
|
2008
|
2007
|
||||||||||||
Impact on Income
before income taxes
|
Impact on Income tax
provision
|
Impact on Income
before income taxes
|
Impact on Income tax
provision
|
||||||||||
(Unaudited)
|
|||||||||||||
Start-up
costs at the Fakenham manufacturing facility related to the integration
of
the Haldane Foods frozen meat-free operations (2008) and the West
Chester
Frozen Foods Facility (2007)
|
$
|
7,490
|
$
|
2,097
|
$
|
1,749
|
$
|
680
|
|||||
SKU
rationalization
|
6,949
|
2,558
|
|||||||||||
Cost
of sales
|
$
|
14,439
|
$
|
4,655
|
$
|
1,749
|
$
|
680
|
|||||
Professional
fees and other expenses incurred in connection with the review of
the
Company's stock option practices
|
$
|
5,774
|
$
|
2,229
|
$
|
281
|
$
|
105
|
|||||
Stock
compensation expense
|
2,129
|
(722
|
)
|
48
|
19
|
||||||||
Severence
and other reorganization costs
|
3,868
|
1,392
|
|||||||||||
SG&A
expenses
|
$
|
11,771
|
$
|
2,899
|
$
|
329
|
$
|
124
|
|||||
Gain
on sale of rice cake factory joint venture
|
$
|
(2,002
|
)
|
$
|
(784
|
)
|
|||||||
Gain
on the sale of Biomarché
|
$
|
(3,401
|
)
|
$
|
(2,177
|
)
|
|||||||
Interest
and other expenses, net
|
$
|
(2,002
|
)
|
$
|
(784
|
)
|
$
|
(3,401
|
)
|
$
|
(2,177
|
)
|
|
Total
adjustments
|
$
|
24,208
|
$
|
6,770
|
$
|
(1,323
|
)
|
$
|
(1,373
|
)
|